Methamphetamine induces DNA damage in specific regions of the female rat brain

Clinical and Experimental Pharmacology and Physiology

Volumn 42, Issue 6, 2015, Pages 570-575

  Johnson, Zane ^a   Venters, Jace ^a   Guarraci, Fay A ^a   Zewail Foote, Maha ^a  

^a SOUTHWESTERN UNIVERSITY   (United States)

Author keywords

Comet assay; DNA damage; DNA strand breaks; Methamphetamine; Rat brain cells

Indexed keywords

DOPAMINE; METHAMPHETAMINE; REACTIVE OXYGEN METABOLITE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ARTICLE; BRAIN; COMET ASSAY; CORPUS STRIATUM; DNA DAMAGE; DNA STRAND BREAKAGE; FEMALE; NEUROTOXICITY; NONHUMAN; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; PREFRONTAL CORTEX; RAT; ANIMAL; DRUG EFFECTS; LONG EVANS RAT; METABOLISM; PHYSIOLOGY;

ANIMALS; BRAIN; CORPUS STRIATUM; DNA DAMAGE; FEMALE; METHAMPHETAMINE; NUCLEUS ACCUMBENS; OXIDATIVE STRESS; RATS; RATS, LONG-EVANS; REACTIVE OXYGEN SPECIES;

EID: 84930322627     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12404     Document Type: Article

References (51)

1. Cho AK, Melega WP. Patterns of methamphetamine abuse and their consequences. J. Addict. Dis. 2001; 21: 21-34.
2. Anglin MD, Burke C, Perrochet B, Stamper E, Dawud-Noursi S. History of the methamphetamine problem. J. Psychoactive Drugs 2000; 32: 137-41.
3. Rusyniak DE. Neurologic manifestations of chronic methamphetamine abuse. Neurol. Clin. 2011; 29: 641.
4. Wise RA, Hoffman DC. Localization of drug reward mechanisms by intracranial injections. Synapse 1992; 10: 247-63.
5. Yamamoto BK, Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 1998; 287: 107-14.
6. Ricaurte GA, Guillery R, Seiden L, Schuster C, Moore R. Dopamine nerve terminal degeneration produced by high doses of methylamphetamine in the rat brain. Brain Res. 1982; 235: 93-103.
7. Sonsalla PK, Nicklas WJ, Heikkila RE. Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity. Science 1989; 243: 398-400.
8. Nash JF, Yamamoto BK. Methamphetamine neurotoxicity and striatal glutamate release: Comparison to 3, 4-methylenedioxymethamphetamine. Brain Res. 1992; 581: 237-43.
9. LaVoie MJ, Hastings TG. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: Evidence against a role for extracellular dopamine. J. Neurosci. 1999; 19: 1484-91.
10. Imam SZ, El-Yazal J, Newport GD et al. Methamphetamine-induced dopaminergic neurotoxicity: Role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts. Ann. N. Y. Acad. Sci. 2001; 939: 366-80.
11. Lucot J, Wagner G, Schuster C, Seiden L. The effects of dopaminergic agents on the locomotor activity of rats after high doses of methylamphetamine. Pharmacol. Biochem. Behav. 1980; 13: 409-13.
12. Nishijima K, Kashiwa A, Hashimoto A, Iwama H, Umino A, Nishikawa T. Differential effects of phencyclidine and methamphetamine on dopamine metabolism in rat frontal cortex and striatum as revealed by in vivo dialysis. Synapse 1996; 22: 304-12.
13. Stephans SE, Yamamoto BK. Effect of repeated methamphetamine administrations on dopamine and glutamate efflux in rat prefrontal cortex. Brain Res. 1995; 700: 99-106.
14. Ernst T, Chang L, Leonido-Yee M, Speck O. Evidence for long-term neurotoxicity associated with methamphetamine abuse A 1H MRS study. Neurology 2000; 54: 1344-9.
15. 2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. Am. J. Psychiatry 2001; 158: 2015-21.
16. Fallon J, Ciofi P. Distribution of monoamines within the amygdala. In: Aggleton JP (ed.). The Amygdala: Neurobiological Aspects of Emotion, Memory, and Mental Dysfunction. Wiley-Liss, New York. 1992; 97-114.
17. Freedman L, Cassell M. Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat. Brain Res. 1994; 633: 243-52.
18. Phillips AG, Ahn S, Howland JG. Amygdalar control of the mesocorticolimbic dopamine system: Parallel pathways to motivated behavior. Neurosci. Biobehav. Rev. 2003; 27: 543-54.
19. Suzuki T, Ishigooka J, Watanabe S, Miyaoka H. Enhancement of delayed release of dopamine in the amygdala induced by conditioned fear stress in methamphetamine-sensitized rats. Eur. J. Pharmacol. 2002; 435: 59-65.
20. 1 dopamine receptor involvement in Pavlovian fear conditioning. Brain Res. 1999; 827: 28-40.
21. Bowyer JF, Ali S. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse 2006; 60: 521-32.
22. Holder MK, Mong JA. Methamphetamine enhances paced mating behaviors and neuroplasticity in the medial amygdala of female rats. Horm. Behav. 2010; 58: 519-25.
23. Giovanni A, Liang LP, Hastings TG, Zigmond MJ. Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: Impact of methamphetamine. J. Neurochem. 1995; 64: 1819-25.
24. Cadet JL, Brannock C. Free radicals and the pathobiology of brain dopamine systems. Neurochem. Int. 1997; 32: 117-31.
25. Krasnova IN, Cadet JL. Methamphetamine toxicity and messengers of death. Brain Res. Rev. 2009; 60: 379-407.
26. Larsen KE, Fon EA, Hastings TG, Edwards RH, Sulzer D. Methamphetamine-induced degeneration of dopaminergic neurons involves autophagy and upregulation of dopamine synthesis. J. Neurosci. 2002; 22: 8951-60.
27. De Vito MJ, Wagner G. Methamphetamine-induced neuronal damage: A possible role for free radicals. Neuropharmacology 1989; 28: 1145-50.
28. Jayanthi S, Ladenheim B, Cadet JL. Methamphetamine-induced changes in antioxidant enzymes and lipid peroxidation in copper/zinc-superoxide dismutase transgenic mice. Ann. N. Y. Acad. Sci. 1998; 844: 92-102.
29. Cadet JL, Sheng P, All S, Rothman R, Carlson E, Epstein C. Attenuation of methamphetamine-induced neurotoxicity in copper/zinc superoxide dismutase transgenic mice. J. Neurochem. 1994; 62: 380-3.
30. Deng X, Wang Y, Chou J, Cadet JL. Methamphetamine causes widespread apoptosis in the mouse brain: Evidence from using an improved TUNEL histochemical method. Mol. Brain Res. 2001; 93: 64-9.
31. Alvarenga TA, Andersen ML, Ribeiro DA et al. Single exposure to cocaine or ecstasy induces DNA damage in brain and other organs of mice. Addict. Biol. 2010; 15: 96-9.
32. de Souza MF, Gonçales TA, Steinmetz A et al. Cocaine induces DNA damage in distinct brain areas of female rats under different hormonal conditions. Clin. Exp. Pharmacol. Physiol. 2014; 41: 265-9.
33. Tice R, Agurell E, Anderson D et al. Single cell gel/comet assay: Guidelines for in vitro and in vivo genetic toxicology testing. Environ. Mol. Mutagen. 2000; 35: 206-21.
34. Jaffe J. Drug addiction and drug abuse. In: Goodman LS, Gilman A (eds). The Pharmacological Basis of Therapeutics. New York, McMillan. 1985; 284-324.
35. Cadet JL, Jayanthi S, Deng X. Speed kills: Cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. FASEB J. 2003; 17: 1775-88.
36. Ferrucci M, Giorgi FS, Bartalucci A, Busceti CL, Fornai F. The effects of locus coeruleus and norepinephrine in methamphetamine toxicity. Curr. Neuropharmacol. 2013; 11: 80.
37. Abercrombie ED, Keefe KA, DiFrischia DS, Zigmond MJ. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J. Neurochem. 1989; 52: 1655-8.
38. Fornai F, Bassi L, Torracca MT, Alessandrì MG, Scalori V, Corsini GU. Region-and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. Neurodegeneration 1996; 5: 241-9.
39. Guilarte T, Nihei M, McGlothan J, Howard A. Methamphetamine-induced deficits of brain monoaminergic neuronal markers: Distal axotomy or neuronal plasticity. Neuroscience 2003; 122: 499-513.
40. Wagner GC, Ricaurte GA, Seiden LS, Schuster CR, Miller RJ, Westley J. Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine. Brain Res. 1980; 181: 151-60.
41. Broening HW, Pu C, Vorhees CV. Methamphetamine selectively damages dopaminergic innervation to the nucleus accumbens core while sparing the shell. Synapse 1997; 27: 153-60.
42. Brown P, Molliver ME. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: Relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J. Neurosci. 2000; 20: 1952-63.
43. Sonsalla PK, Riordan DE, Heikkila RE. Competitive and noncompetitive antagonists at N-methyl-D-aspartate receptors protect against methamphetamine-induced dopaminergic damage in mice. J. Pharmacol. Exp. Ther. 1991; 256: 506-12.
44. Marshall J, O'Dell S, Weihmuller F. Dopamine-glutamate interactions in methamphetamine-induced neurotoxicity. J. Neural. Transm. 1993; 91: 241-54.
45. Hattori A, Luo Y, Umegaki H, Munoz J, Roth GS. Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats. NeuroReport 1998; 9: 2569-72.
46. Parsegian A, See RE. Dysregulation of dopamine and glutamate release in the prefrontal cortex and nucleus accumbens following methamphetamine self-administration and during reinstatement in rats. Neuropsychopharmacology 2014; 39: 811-22.
47. Wang X, Michaelis EK. Selective neuronal vulnerability to oxidative stress in the brain. Front. Aging Neurosci. 2010; 2: 1-13.
48. Liu J, Head E, Gharib AM et al. Memory loss in old rats is associated with brain mitochondrial decay and RNA/DNA oxidation: Partial reversal by feeding acetyl-L-carnitine and/or R-α-lipoic acid. Proc. Natl Acad. Sci. USA 2002; 99: 2356-61.
49. Markesbery WR, Lovell MA. Damage to lipids, proteins, DNA, and RNA in mild cognitive impairment. Arch. Neurol. 2007; 64: 954-6.
50. Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. J. Neuropsychiatry Clin. Neurosci. 2003; 15: 317-25.
51. Paxionos G, Watson C. The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, San Diego. Copyright © 1998.